1. |
李超. 中国癌症流行的国际比较. 中国肿瘤, 2016, 25(6): 409-414.
|
2. |
中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作委员会, 中华医学会肝病学分会肝癌学. 原发性肝癌规范化诊治专家共识. 临床肿瘤学杂志, 2009, 14(3): 259-269.
|
3. |
Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria. J Gastroenterol Hepatol, 2014, 29(7): 1500-1507.
|
4. |
Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology, 2011, 53(3): 1020-1022.
|
5. |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 临床肝胆病杂志, 2020, 36(2): 277-292.
|
6. |
中国医师协会器官移植医师分会, 中华医学会器官移植学分会. 中国肝癌肝移植临床实践指南(2018版). 临床肝胆病杂志, 2019, 35(2): 275-280.
|
7. |
Lu LH, Mei J, Kan A, et al. Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation. Cancer Med, 2020, 9(9): 2997-3005.
|
8. |
李雪梅, 王博方, 马延龄. 复发肝癌的诊断与治疗. 中华肝脏外科手术学电子杂志, 2020, 9(2): 116-122.
|
9. |
Chen X, Chen Y, Li Q, et al. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis. J Surg Res, 2015, 195(1): 166-174.
|
10. |
Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol, 2014, 37(3): 705-715.
|
11. |
Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol, 2007, 14(8): 2319-2329.
|
12. |
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis, 2010, 30(1): 52-60.
|
13. |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6 336 patients and results of a survey. Ann Surg, 2004, 240(2): 205-213.
|
14. |
侯帅, 樊琳琳. 非手术治疗原发性肝癌研究进展. 实用肝脏病杂志, 2016, 19(2): 249-252.
|
15. |
Mazzaferro V, Lencioni R, Majno P. Early hepatocellular carcinoma on the procrustean bed of ablation, resection, and transplantation. Semin Liver Dis, 2014, 34(4): 415-426.
|
16. |
Huang ZM, Li W, Li S, et al. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. J Immunother, 2013, 36(5): 287-293.
|
17. |
Chen H, Wu MC, Luo XJ, et al. An analysis of prospective outcome of re-resection for recurrent live cancer and extrahepatic metastases, a follow-up of 267 cases. Chin-Ger J Clin Onco, 2003, 2(1): 2-9.
|
18. |
Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol, 2008, 15(12): 3484-3493.
|
19. |
Takahashi H, Mizuta T, Kawazoe S, et al. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol Res, 2010, 40(10): 997-1005.
|
20. |
Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg, 2003, 237(2): 171-179.
|
21. |
Zhang X, Li C, Wen T, et al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur J Gastroenterol Hepatol, 2015, 27(8): 933-940.
|
22. |
Eisele RM, Chopra SS, Lock JF, et al. Treatment of recurrent hepatocellular carcinoma confined to the liver with repeated resection and radiofrequency ablation: a single center experience. Technol Health Care, 2013, 21(1): 9-18.
|
23. |
Hasegawa K, Aoki T, Ishizawa T, et al. Comparison of the therapeutic outcomes between surgical resection and percutaneous ablation for small hepatocellular carcinoma. Ann Surg Oncol, 2014, 21(Suppl 3): S348-S355.
|
24. |
中国抗癌协会肿瘤介入学专业委员会, 上海市抗癌协会实体肿瘤聚焦诊疗专业委员会. 影像导引肝脏恶性肿瘤多模态消融治疗技术专家共识. 临床肝胆病杂志, 2018, 34(10): 2098-2102.
|
25. |
Wang Q, Blank S, Fiel MI, et al. The severity of liver fibrosis influences the prognostic value of inflammation-based scores in hepatitis B-associated hepatocellular carcinoma. Ann Surg Oncol, 2015, 22(Suppl 3): S1125-S1132.
|
26. |
安松林, 荣维淇, 王黎明. 甲胎蛋白阴性和甲胎蛋白阳性肝细胞癌临床病理特征及R0切除后生存分析. 中华肿瘤杂志, 2015, 37(4): 308-311.
|
27. |
Bertrand J, Caillol F, Borentain P, et al. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med, 2015, 7: 21-27.
|
28. |
Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients–mathematic model, overlapping mode, and electrode placement process. Radiology, 2004, 232(1): 260-271.
|